CPHI (STOCKS)
China Pharma Holdings, Inc.
$0.649800
+0.003900 (+0.60%)
Prev close: $0.645900
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Zhi Lin Li
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $26.33M
- Employees
- 231
- P/E (TTM)
- -0.87
- P/B (TTM)
- 0.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2011 (Q3)
|
$40.00 | $61.20 | -21.2000 | -34.64% |
|
Jun 2011 (Q2)
|
$60.00 | $56.10 | +3.9000 | +6.95% |
|
Mar 2011 (Q1)
|
$50.00 | $58.65 | -8.6500 | -14.75% |
|
Dec 2010 (Q4)
|
$75.00 | $79.90 | -4.9017 | -6.13% |
Financial Statements
| Revenues | $4.14M |
| Benefits Costs and Expenses | $7.33M |
| Cost Of Revenue | $4.28M |
| Costs And Expenses | $7.33M |
| Gross Profit | -$131.95K |
| Nonoperating Income/Loss | $51.52K |
| Operating Expenses | $3.11M |
| Research and Development | $280.90K |
| Other Operating Expenses | $2.83M |
| Operating Income/Loss | -$3.24M |
| Income/Loss From Continuing Operations After Tax | -$3.19M |
| Income/Loss From Continuing Operations Before Tax | -$3.19M |
| Interest Expense, Operating | $27.27K |
| Net Income/Loss | -$3.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.74 |
| Diluted Earnings Per Share | -$0.74 |
| Basic Average Shares | 4,291,427 |
| Assets | $31.00M |
| Current Assets | $2.35M |
| Inventory | $1.62M |
| Prepaid Expenses | $82.37K |
| Other Current Assets | $642.62K |
| Noncurrent Assets | $28.65M |
| Fixed Assets | $4.39M |
| Intangible Assets | $24.08M |
| Other Non-current Assets | $181.83K |
| Liabilities | $8.26M |
| Current Liabilities | $7.40M |
| Noncurrent Liabilities | $859.35K |
| Equity | $22.74M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $22.74M |
| Liabilities And Equity | $31.00M |
| Net Cash Flow From Operating Activities | $148.26K |
| Net Cash Flow From Operating Activities, Continuing | $70.00K |
| Net Cash Flow From Investing Activities | -$137.25K |
| Net Cash Flow From Investing Activities, Continuing | -$137.25K |
| Net Cash Flow From Financing Activities | -$294.03K |
| Net Cash Flow From Financing Activities, Continuing | -$294.03K |
| Exchange Gains/Losses | $1.25K |
| Net Cash Flow | -$281.77K |
| Net Cash Flow, Continuing | -$361.28K |
| Comprehensive Income/Loss | -$2.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.92M |
| Other Comprehensive Income/Loss | -$2.92M |